Research Reports

Healthcare

icon
Home » Reports » Needle Free Insulin Devices Market Global Historical Growth 2012 2016 Future Outlook 2017 2024 Demand Analysis Opportunity Evaluation
Market Research Report

Needle Free Insulin Devices Market : Global Historical Growth (2012-2016) & Future Outlook (2017-2024) Demand Analysis & Opportunity Evaluation

Published On : 09:40 AM, 14th September, 2017 REP-ID-488 Category: Healthcare

Needle Free Insulin Devices Market Overview

Needle free insulin devices are one of the types of insulin delivery devices. Further, needle free insulin devices use jet technology for insulin injection instead of needles. These are the needle free devices which are used to inject insulin into the tissue under the skin without any use of needle. The aim behind this technology is to provide better insulin delivery devices to the patients suffering from diabetes. Moreover, use of needle free insulin devices is painless and as effective as needle insulin devices. Needle free insulin devices are highly acceptable in those situations where insulin injection is the only option for the treatment. This technology is also very useful in treatment of those patients who have fear with needles.

Market Size & Forecast

Global needle free insulin devices market is predicated to experience a massive growth during the forecast period i.e. 2017-2024. Various factors such as growing technological advancement with medical devices, growing geriatric population and increasing number of people suffering from diabetes are anticipated to foster the growth of global needle free insulin market during the forecast period.

Moreover, market of needle free insulin devices is expected to expand on the back of growing insulin devices market. On the basis of geography, global needle free insulin devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

North America is expected to be the major market of needle free insulin devices during the forecast period. Additionally, presences of large geriatric population coupled with growing number of patients suffering from diabetics are some major factors likely to fuel the growth of market in North America region. U.S is predicted to be the dominating country in North America region due to high adoption rate of advanced technology in this country.

Needle Free Insulin Device

Furthermore, Asia Pacific region is believed to witness remarkable growth during the forecast period. This growth in Asia Pacific region can be attributed to large base of population suffering from diabetic problems and growing awareness regarding healthcare amongst the consumers.

China, India and Japan are likely to be the key countries to the growth of market in Asia Pacific region over the forecast period.  

Furthermore, Europe region is also projected to grow at remarkable pace during the forecast period owing to the key factors such as high expenditure by consumers on health care and growing adoption of potential technologies in health industries in this region.

By end user, home care is anticipated to be the major consuming area due to increasing adoption of insulin delivery devices amongst the patient suffering from diabetic. Further, rising development of advance insulin delivery devices such as needle free insulin device is a major factor which is likely to allow homecare to behold its dominance during the forecast period.

Market Segmentations

Our-in depth analysis of the global needle free insulin devices market includes the following:

By End User

  • Homecare
  • Hospitals
  • Clinics
  • Others

By Components

  • Injector
  • Syringe
  • Filling Adapter
  • Reset Station

By Product

  • Fillable
  • Prefilled

By Region

Global needle free insulin devices market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, South Korea & Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (GCC, North Africa, South Africa & Rest of Middle East & Africa) Market Size and Y-O-Y Growth Analysis

Needle Free Insulin Devices Market

Growth Drivers & Challenges

Global needle free insulin devices market is expected to be driven by various factors such as growing number of individuals suffering from diabetic related problems coupled with rising adoption of insulin delivery devices by diabetic patients. Further, growing concerns amongst the consumers regarding health care is a major factor responsible for rise in adoption of needle free insulin devices.

Moreover, increasing geriatric population coupled with rising adoption of homecare treatment by aged people is likely to be the key factor which is expected to drive the growth of global market. Additionally, rapid technological advancements with medical devices are also envisioned to foster the growth of global market of needle free insulin devices market.

Furthermore, growing disposable income of the consumers and increasing spending on health care are predicated to be the dynamic factors behind the growth of global market. Apart from this, needle free insulin devices are highly adopted by those patients who have fear or strong dislike for needles. Further, this key factor is anticipated to foster the growth of global needle free insulin devices market in near future.

However, high cost of needle free insulin devices is a major challenge to the market of needle free insulin devices market. Additionally, lack of unavailability of this product in some emerging economies is likely to hinder the growth of global market of needle free insulin devices.

Key Players

The major players for needle free insulin devices market are as follows:

  • CareSens
  • Injex Pharma AG
  • European Pharma Group
  • ASTS Enterprises Pty Ltd.
  • PharmaCo Ltd.

Key potential companies that may enter into the manufacturing of needle free insulin devices are:

  • PharmaJet
  • Antares Pharma Inc.
  • Endo International PLC
  • Bioject Medical Technologies Inc.
  • Medical International Technology Inc.
  • National Medical Products Inc.

Scope & Context

Overview of the Parent Market

Analyst View

Segmentation

The global needle free insulin devices market is segmented as follows:

  • By End User Melanoma Market Size & Y-O-Y Growth Analysis
  • By Component Market Size & Y-O-Y Growth Analysis
  • By Product Market Size & Y-O-Y Growth Analysis
  • By Region Market Size & Y-O-Y Growth Analysis

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

 

Key Answers Captured in Report?
Which geography would have better demand for product/services?
What are the strategies adopted by big players in the regional market?
Which country would see the steep rise in CAGR & year-on-year (Y-O-Y) growth?
What is the current & expected market size in next five years?
What is the market feasibility for long term investment?
What opportunity the country would offer for existing and new players in the market?
What is risk involved for suppliers in the geography?
What factors would drive the demand for the product/service in near future?
What is the impact analysis of various factors in the market growth?
What are the recent trends in the regional market and how successful they are?

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Ask The Analyst

Delivery Center

1014, 10th Floor, Tower A1,
Ansal Corporate Park, Plot no 7A/1,
Sector 142 Noida., 201301 India
Phone : +91 958 228 3827, +91 120 660 5495
info@researchnester.com

US Office

1820 Avenue M, Suite# 1113,
Brooklyn, New York 11230
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com

UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Copyright © 2017 Research Nester. All rights reserved

Top